| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin DNA binding | 5.64e-05 | 167 | 80 | 6 | GO:0031490 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 1.51e-04 | 67 | 80 | 4 | GO:0031492 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HBS1L DNAH10 DDX52 SMCHD1 DDX18 ARL13B EIF5B NAV1 GNAO1 DDX27 DHX8 | 2.56e-04 | 775 | 80 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 2.64e-04 | 417 | 80 | 8 | GO:0140098 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 2.72e-04 | 78 | 80 | 4 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 3.00e-04 | 80 | 80 | 4 | GO:0008186 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HBS1L DNAH10 DDX52 SMCHD1 DDX18 ARL13B EIF5B NAV1 GNAO1 DDX27 DHX8 | 5.01e-04 | 839 | 80 | 11 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HBS1L DNAH10 DDX52 SMCHD1 DDX18 ARL13B EIF5B NAV1 GNAO1 DDX27 DHX8 | 5.06e-04 | 840 | 80 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HBS1L DNAH10 DDX52 SMCHD1 DDX18 ARL13B EIF5B NAV1 GNAO1 DDX27 DHX8 | 5.06e-04 | 840 | 80 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | nucleosome binding | 6.48e-04 | 98 | 80 | 4 | GO:0031491 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 6.99e-04 | 10 | 80 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.84e-03 | 562 | 80 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.94e-03 | 441 | 80 | 7 | GO:0016887 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | RLF FAM47A RIF1 SETD2 MYBBP1A PSIP1 ATR KDM5A SMCHD1 H1-2 H1-3 H1-4 KMT2A SMARCD2 CDY2A MECP2 | 1.41e-08 | 741 | 78 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | RLF FAM47A RIF1 SETD2 MYBBP1A PSIP1 ATR KDM5A SMCHD1 H1-2 H1-3 H1-4 KMT2A SMARCD2 CDY2A MECP2 | 1.93e-07 | 896 | 78 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | RLF FAM47A RIF1 SETD2 MYBBP1A PSIP1 ATR KDM5A SMCHD1 H1-2 H1-3 H1-4 KMT2A SMARCD2 CDY2A MECP2 | 8.25e-07 | 999 | 78 | 16 | GO:0071824 |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination | 2.04e-06 | 55 | 78 | 5 | GO:0045910 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 2.23e-05 | 150 | 78 | 6 | GO:0000018 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA metabolic process | 2.69e-05 | 155 | 78 | 6 | GO:0051053 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 3.57e-05 | 163 | 78 | 6 | GO:0031507 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 1.20e-04 | 203 | 78 | 6 | GO:0045814 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 1.39e-04 | 515 | 78 | 9 | GO:0022613 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 1.88e-04 | 75 | 78 | 4 | GO:0032922 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 2.03e-04 | 142 | 78 | 5 | GO:0034728 | |
| GeneOntologyBiologicalProcess | negative regulation of heterochromatin formation | 2.10e-04 | 6 | 78 | 2 | GO:0031452 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 2.31e-04 | 146 | 78 | 5 | GO:2000779 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 2.51e-04 | 330 | 78 | 7 | GO:0040029 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 2.60e-04 | 234 | 78 | 6 | GO:0006282 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 2.73e-04 | 564 | 78 | 9 | GO:0051052 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 2.81e-04 | 336 | 78 | 7 | GO:0042254 | |
| GeneOntologyBiologicalProcess | negative regulation of chromatin organization | 2.93e-04 | 7 | 78 | 2 | GO:1905268 | |
| GeneOntologyCellularComponent | chromatin | FAM47A KANSL1L NRIP1 RIF1 MYBBP1A AHRR TADA1 BBX PSIP1 KDM5A EGR3 H1-2 H1-3 H1-4 SMARCD2 ELF1 ADNP MECP2 | 1.13e-05 | 1480 | 81 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | euchromatin | 1.76e-04 | 72 | 81 | 4 | GO:0000791 | |
| Domain | Histone_H5 | 4.17e-06 | 8 | 80 | 3 | IPR005819 | |
| Domain | H15 | 2.10e-05 | 13 | 80 | 3 | SM00526 | |
| Domain | Linker_histone | 2.10e-05 | 13 | 80 | 3 | PF00538 | |
| Domain | H15 | 2.10e-05 | 13 | 80 | 3 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 2.66e-05 | 14 | 80 | 3 | IPR005818 | |
| Domain | DEAD/DEAH_box_helicase_dom | 2.71e-04 | 73 | 80 | 4 | IPR011545 | |
| Domain | DEAD | 2.71e-04 | 73 | 80 | 4 | PF00270 | |
| Domain | DEAD_ATP_HELICASE | 3.12e-04 | 31 | 80 | 3 | PS00039 | |
| Domain | Q_MOTIF | 5.29e-04 | 37 | 80 | 3 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 5.29e-04 | 37 | 80 | 3 | IPR014014 | |
| Domain | Helicase_C | 1.15e-03 | 107 | 80 | 4 | PF00271 | |
| Domain | HELICc | 1.15e-03 | 107 | 80 | 4 | SM00490 | |
| Domain | Znf_C2H2_matrin | 1.16e-03 | 12 | 80 | 2 | IPR000690 | |
| Domain | Helicase_C | 1.19e-03 | 108 | 80 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.23e-03 | 109 | 80 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.23e-03 | 109 | 80 | 4 | PS51192 | |
| Domain | DEXDc | 1.23e-03 | 109 | 80 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.28e-03 | 110 | 80 | 4 | IPR014001 | |
| Domain | - | 1.28e-03 | 746 | 80 | 10 | 3.40.50.300 | |
| Domain | Post-SET_dom | 2.09e-03 | 16 | 80 | 2 | IPR003616 | |
| Domain | PostSET | 2.09e-03 | 16 | 80 | 2 | SM00508 | |
| Domain | AT_hook | 2.09e-03 | 16 | 80 | 2 | PF02178 | |
| Domain | POST_SET | 2.09e-03 | 16 | 80 | 2 | PS50868 | |
| Domain | - | 2.45e-03 | 218 | 80 | 5 | 1.10.10.10 | |
| Domain | aa-tRNA-synth_I_CS | 2.65e-03 | 18 | 80 | 2 | IPR001412 | |
| Domain | ZF_MATRIN | 2.65e-03 | 18 | 80 | 2 | PS50171 | |
| Domain | EFTu-like_2 | 2.65e-03 | 18 | 80 | 2 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 2.65e-03 | 18 | 80 | 2 | PF03144 | |
| Domain | G_TR_2 | 2.65e-03 | 18 | 80 | 2 | PS51722 | |
| Domain | TF_GTP-bd_dom | 2.96e-03 | 19 | 80 | 2 | IPR000795 | |
| Domain | AA_TRNA_LIGASE_I | 2.96e-03 | 19 | 80 | 2 | PS00178 | |
| Domain | P-loop_NTPase | 3.27e-03 | 848 | 80 | 10 | IPR027417 | |
| Domain | WHTH_DNA-bd_dom | 3.83e-03 | 242 | 80 | 5 | IPR011991 | |
| Domain | PHD | 4.09e-03 | 75 | 80 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 4.74e-03 | 79 | 80 | 3 | IPR019787 | |
| Domain | Transl_B-barrel | 5.93e-03 | 27 | 80 | 2 | IPR009000 | |
| Domain | AT_hook | 5.93e-03 | 27 | 80 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 5.93e-03 | 27 | 80 | 2 | IPR017956 | |
| Domain | PHD | 6.60e-03 | 89 | 80 | 3 | SM00249 | |
| Domain | ZnF_U1 | 6.82e-03 | 29 | 80 | 2 | SM00451 | |
| Domain | Znf_U1 | 6.82e-03 | 29 | 80 | 2 | IPR003604 | |
| Domain | Znf_PHD | 7.01e-03 | 91 | 80 | 3 | IPR001965 | |
| Domain | HMGI/Y_DNA-bd_CS | 7.77e-03 | 31 | 80 | 2 | IPR000637 | |
| Domain | ZF_PHD_2 | 7.89e-03 | 95 | 80 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 8.12e-03 | 96 | 80 | 3 | PS01359 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 1.93e-05 | 13 | 59 | 3 | M1018 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 4.54e-05 | 17 | 59 | 3 | M27189 | |
| Pubmed | CUL4B RIF1 MYBBP1A DDX52 SMCHD1 AHNAK DDX18 RPF2 H1-3 H1-4 ZNF638 EIF5B KMT2A DIDO1 ADNP DDX27 DHX8 | 1.54e-13 | 653 | 81 | 17 | 22586326 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF512B CUL4B RIF1 SETD2 MYBBP1A BBX PSIP1 SMCHD1 AHNAK DDX18 WBP4 H1-2 ZNF638 EIF5B KMT2A DIDO1 ADNP MECP2 FKBP3 | 5.42e-13 | 954 | 81 | 19 | 36373674 |
| Pubmed | CUL4B S100A4 RIF1 SETD2 MYBBP1A PSIP1 ATR SMCHD1 AHNAK DDX18 H1-2 EIF5B KMT2A DIDO1 SMARCD2 PSME1 ADNP FKBP3 YARS1 | 1.57e-12 | 1014 | 81 | 19 | 32416067 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYBBP1A PSIP1 DDX52 SMCHD1 AHNAK DDX18 RPF2 H1-3 ZNF638 EIF5B NAV1 DIDO1 SMARCD2 ADNP MECP2 DDX27 FKBP3 YARS1 FAM83B DHX8 | 7.19e-12 | 1257 | 81 | 20 | 36526897 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF512B RLF RIF1 BBX PSIP1 KDM5A CWC27 SMCHD1 KMT2A DIDO1 SMARCD2 ELF1 ADNP MECP2 DHX8 | 1.03e-11 | 608 | 81 | 15 | 36089195 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF512B RIF1 SETD2 MYBBP1A BBX PSIP1 ATR KDM5A DDX52 SMCHD1 AHNAK DDX18 H1-2 H1-4 ZNF638 KMT2A DIDO1 ADNP MECP2 DHX8 | 1.21e-11 | 1294 | 81 | 20 | 30804502 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | S100A4 NRIP1 HBS1L MYBBP1A KDM5A DDX52 SMCHD1 AHNAK DDX18 RPF2 H1-2 H1-3 H1-4 EIF5B KMT2A DIDO1 SMARCD2 ADNP DDX27 YARS1 | 1.68e-11 | 1318 | 81 | 20 | 30463901 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | RIF1 MYBBP1A BBX PSIP1 SMCHD1 DDX18 RPF2 H1-3 EIF5B KMT2A SMARCD2 ADNP MECP2 DDX27 | 2.37e-11 | 533 | 81 | 14 | 30554943 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | CUL4B RIF1 MYBBP1A BBX PSIP1 SMCHD1 ZNF638 DIDO1 ADNP MECP2 DHX8 | 6.24e-11 | 283 | 81 | 11 | 30585729 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | RIF1 MYBBP1A DDX52 SMCHD1 AHNAK DDX18 H1-2 ZNF638 KMT2A DIDO1 DDX27 YARS1 | 1.32e-10 | 394 | 81 | 12 | 27248496 |
| Pubmed | RIF1 MYBBP1A PSIP1 SMCHD1 AHNAK DDX18 RPF2 H1-2 H1-4 ZNF638 DIDO1 RAB11FIP1 ADNP DDX27 | 3.31e-10 | 652 | 81 | 14 | 31180492 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | CUL4B RIF1 MYBBP1A SMCHD1 RPF2 ZNF638 EIF5B KMT2A DIDO1 ADNP DDX27 | 4.51e-10 | 341 | 81 | 11 | 32971831 |
| Pubmed | ADAMTS12 MYBBP1A BBX PSIP1 KDM5A CWC27 DDX52 SMCHD1 AHNAK PAEP RPF2 H1-2 H1-3 H1-4 EIF5B KMT2A SMARCD2 GNAO1 MECP2 | 6.32e-10 | 1442 | 81 | 19 | 35575683 | |
| Pubmed | 1.32e-09 | 86 | 81 | 7 | 37253089 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ZNF512B RIF1 MYBBP1A PSIP1 DDX52 SMCHD1 AHNAK DDX18 RPF2 H1-4 ZNF638 EIF5B ADNP DDX27 FAM83B DHX8 | 1.59e-09 | 1024 | 81 | 16 | 24711643 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RIF1 HBS1L MYBBP1A PSIP1 ATR DNAH10 DDX52 SMCHD1 DDX18 RPF2 H1-2 CARS1 EIF5B ADNP DDX27 FKBP3 YARS1 DHX8 | 3.74e-09 | 1425 | 81 | 18 | 30948266 |
| Pubmed | ZNF512B RLF RIF1 MYBBP1A TADA1 BBX DNAH10 KDM5A DDX52 SMCHD1 DDX18 ZNF638 KMT2A DIDO1 SMARCD2 ELF1 ADNP DDX27 | 3.91e-09 | 1429 | 81 | 18 | 35140242 | |
| Pubmed | 6.90e-09 | 339 | 81 | 10 | 30415952 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 26209608 | ||
| Pubmed | High-resolution mapping of h1 linker histone variants in embryonic stem cells. | 1.22e-08 | 3 | 81 | 3 | 23633960 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 21245380 | ||
| Pubmed | CUL4B MYBBP1A PSIP1 SMCHD1 AHNAK WBP4 H1-3 ZNF638 KMT2A SMARCD2 MECP2 | 1.24e-08 | 469 | 81 | 11 | 27634302 | |
| Pubmed | RIF1 MYBBP1A DDX52 DDX18 RPF2 H1-2 H1-4 ZNF638 EIF5B DDX27 DHX8 | 1.67e-08 | 483 | 81 | 11 | 36912080 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RIF1 HBS1L MYBBP1A PSIP1 SMCHD1 AHNAK DDX18 H1-2 CARS1 ZNF638 EIF5B NAV1 DIDO1 PSME1 FKBP3 YARS1 DHX8 | 2.27e-08 | 1415 | 81 | 17 | 28515276 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | HBS1L MYBBP1A PSIP1 SMCHD1 AHNAK DDX18 CARS1 EIF5B NAV1 GNAO1 FKBP3 | 2.29e-08 | 498 | 81 | 11 | 36634849 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZNF512B SETD2 MYBBP1A BBX PSIP1 KDM5A DDX18 RPF2 ZNF638 EIF5B DIDO1 ADNP MECP2 FKBP3 DHX8 | 2.69e-08 | 1082 | 81 | 15 | 38697112 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL4B RIF1 SETD2 MYBBP1A PSIP1 ATR KDM5A ZNF638 EIF5B KMT2A DIDO1 ELF1 MECP2 | 2.78e-08 | 774 | 81 | 13 | 15302935 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZNF512B RIF1 SETD2 MYBBP1A PSIP1 SMCHD1 AHNAK H1-4 ZNF638 EIF5B KMT2A DIDO1 ADNP FKBP3 | 3.17e-08 | 934 | 81 | 14 | 33916271 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | MYBBP1A PSIP1 DDX52 DDX18 RPF2 H1-2 H1-3 H1-4 ZNF638 EIF5B DIDO1 DDX27 DHX8 | 4.51e-08 | 807 | 81 | 13 | 22681889 |
| Pubmed | H1 linker histones are essential for mouse development and affect nucleosome spacing in vivo. | 4.86e-08 | 4 | 81 | 3 | 12808097 | |
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 11746507 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 10997781 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 11689686 | ||
| Pubmed | 4.86e-08 | 16 | 81 | 4 | 33288900 | ||
| Pubmed | 5.08e-08 | 419 | 81 | 10 | 15635413 | ||
| Pubmed | RIF1 HBS1L SETD2 BBX KDM5A CWC27 DDX52 RPF2 EIF5B KMT2A DIDO1 RAB11FIP1 MECP2 DDX27 FKBP3 FAM83B DHX8 | 5.14e-08 | 1497 | 81 | 17 | 31527615 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RALGAPA1 RIF1 MYBBP1A CWC27 DDX52 SMCHD1 AHNAK DDX18 RPF2 H1-2 ZNF638 DIDO1 ADNP DDX27 | 6.41e-08 | 989 | 81 | 14 | 36424410 |
| Pubmed | 8.40e-08 | 156 | 81 | 7 | 37108203 | ||
| Pubmed | The mouse histone H1 genes: gene organization and differential regulation. | 1.21e-07 | 5 | 81 | 3 | 9300059 | |
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 11467742 | ||
| Pubmed | A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences. | 1.21e-07 | 5 | 81 | 3 | 8003976 | |
| Pubmed | Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. | 1.21e-07 | 5 | 81 | 3 | 10893414 | |
| Pubmed | Expression of murine H1 histone genes during postnatal development. | 1.21e-07 | 5 | 81 | 3 | 9655912 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 1.29e-07 | 349 | 81 | 9 | 25665578 | |
| Pubmed | MYBBP1A DDX18 RPF2 H1-2 CARS1 ZNF638 EIF5B SMARCD2 POLR2M PSME1 DDX27 | 1.91e-07 | 615 | 81 | 11 | 31048545 | |
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 2.10e-07 | 56 | 81 | 5 | 26919559 | |
| Pubmed | Characterization of phosphorylation sites on histone H1 isoforms by tandem mass spectrometry. | 2.42e-07 | 6 | 81 | 3 | 15595731 | |
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 15562002 | ||
| Pubmed | The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone. | 2.42e-07 | 6 | 81 | 3 | 21425800 | |
| Pubmed | Hormone-mediated dephosphorylation of specific histone H1 isoforms. | 2.42e-07 | 6 | 81 | 3 | 11479299 | |
| Pubmed | Linker histone transitions during mammalian oogenesis and embryogenesis. | 2.42e-07 | 6 | 81 | 3 | 9499577 | |
| Pubmed | Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-β-catenin signaling pathway. | 2.42e-07 | 6 | 81 | 3 | 22083958 | |
| Pubmed | H1 family histones in the nucleus. Control of binding and localization by the C-terminal domain. | 2.42e-07 | 6 | 81 | 3 | 15911621 | |
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 24435047 | ||
| Pubmed | All known human H1 histone genes except the H1(0) gene are clustered on chromosome 6. | 4.23e-07 | 7 | 81 | 3 | 8325638 | |
| Pubmed | ZNF512B RIF1 MYBBP1A PSIP1 DDX52 DDX18 RPF2 H1-4 ZNF638 KMT2A DDX27 DHX8 | 6.11e-07 | 847 | 81 | 12 | 35850772 | |
| Pubmed | Histone h1 depletion impairs embryonic stem cell differentiation. | 6.76e-07 | 8 | 81 | 3 | 22589736 | |
| Pubmed | Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1. | 1.01e-06 | 9 | 81 | 3 | 24412544 | |
| Pubmed | 1.11e-06 | 332 | 81 | 8 | 25693804 | ||
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | MYBBP1A PSIP1 DDX52 DDX18 ARL13B H1-2 H1-3 H1-4 RAB11FIP1 DDX27 | 1.44e-06 | 604 | 81 | 10 | 37616343 |
| Pubmed | Dynamic changes in H1 subtype composition during epigenetic reprogramming. | 1.44e-06 | 10 | 81 | 3 | 28794128 | |
| Pubmed | High-throughput kinase assays with protein substrates using fluorescent polymer superquenching. | 1.44e-06 | 10 | 81 | 3 | 15927069 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ZNF512B MYBBP1A PSIP1 DDX52 DDX18 H1-2 ZNF638 KMT2A ADNP DDX27 | 1.46e-06 | 605 | 81 | 10 | 28977666 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RIF1 MYBBP1A PSIP1 DDX52 SMCHD1 DDX18 H1-4 DIDO1 DDX27 FKBP3 DHX8 | 1.51e-06 | 759 | 81 | 11 | 35915203 |
| Pubmed | ZNF512B RALGAPA1 C5orf34 MYBBP1A MOSPD2 PSIP1 DDX18 RPF2 ARL13B EIF5B AKAP11 RAB11FIP1 C9orf72 DDX27 FAM83B | 1.55e-06 | 1487 | 81 | 15 | 33957083 | |
| Pubmed | RLF PSIP1 SMCHD1 H1-2 EIF5B KMT2A DIDO1 SMARCD2 ELF1 PSME1 ADNP MECP2 FKBP3 | 1.56e-06 | 1103 | 81 | 13 | 34189442 | |
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 1.70e-06 | 37 | 81 | 4 | 36835656 | |
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 1.98e-06 | 11 | 81 | 3 | 26689747 | |
| Pubmed | 2.02e-06 | 250 | 81 | 7 | 33536335 | ||
| Pubmed | 2.58e-06 | 645 | 81 | 10 | 25281560 | ||
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 2.64e-06 | 12 | 81 | 3 | 22650316 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RLF RIF1 HBS1L MYBBP1A DDX52 SMCHD1 AHNAK DDX18 RPF2 H1-2 ZNF638 EIF5B ADNP DDX27 | 2.71e-06 | 1353 | 81 | 14 | 29467282 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYBBP1A PSIP1 AHNAK DDX18 H1-2 H1-3 H1-4 EIF5B KMT2A PSME1 FKBP3 | 2.72e-06 | 807 | 81 | 11 | 30575818 |
| Pubmed | 2.96e-06 | 655 | 81 | 10 | 35819319 | ||
| Pubmed | RIF1 MYBBP1A PSIP1 KDM5A DDX52 SMCHD1 AHNAK DDX18 KMT2A DIDO1 SMARCD2 MECP2 DDX27 FKBP3 | 3.16e-06 | 1371 | 81 | 14 | 36244648 | |
| Pubmed | 3.42e-06 | 13 | 81 | 3 | 8858344 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.29e-06 | 410 | 81 | 8 | 26949251 | |
| Pubmed | Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. | 5.34e-06 | 49 | 81 | 4 | 27352031 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24873882 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23318960 | ||
| Pubmed | SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia. | 5.36e-06 | 2 | 81 | 2 | 29249820 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22275515 | ||
| Pubmed | MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. | 5.36e-06 | 2 | 81 | 2 | 29777171 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34502373 | ||
| Pubmed | Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression. | 5.36e-06 | 2 | 81 | 2 | 34958665 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34074749 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26235378 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 37100882 | ||
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | 5.85e-06 | 191 | 81 | 6 | 21907836 | |
| Pubmed | MYBBP1A SMCHD1 DDX18 H1-2 H1-4 KMT2A PSME1 DDX27 FKBP3 YARS1 | 6.09e-06 | 711 | 81 | 10 | 33022573 | |
| Pubmed | 6.24e-06 | 713 | 81 | 10 | 29802200 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 6.32e-06 | 714 | 81 | 10 | 28302793 | |
| Pubmed | TSNAXIP1 SMCHD1 DDX18 WBP4 H1-4 EIF5B MECP2 FKBP3 YARS1 DHX8 | 7.05e-06 | 723 | 81 | 10 | 34133714 | |
| Pubmed | 8.05e-06 | 202 | 81 | 6 | 24639526 | ||
| Pubmed | 9.68e-06 | 18 | 81 | 3 | 24025402 | ||
| Pubmed | ZNF512B SETD2 CWC27 SMCHD1 DDX18 H1-3 ZNF638 DIDO1 RAB11FIP1 YARS1 | 1.01e-05 | 754 | 81 | 10 | 35906200 | |
| Pubmed | ZNF512B CUL4B SETD2 TADA1 KDM5A DDX52 DDX18 H1-2 H1-4 SMARCD2 RAB11FIP1 MECP2 | 1.03e-05 | 1116 | 81 | 12 | 31753913 | |
| Pubmed | 1.05e-05 | 123 | 81 | 5 | 35583604 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYBBP1A PSIP1 DDX52 AHNAK DDX18 H1-2 H1-3 H1-4 EIF5B DDX27 DHX8 | 1.25e-05 | 949 | 81 | 11 | 36574265 |
| Pubmed | RIF1 MYBBP1A DENND6A BBX AHNAK DDX18 ARL13B H1-4 ZNF638 FAM83B | 1.32e-05 | 777 | 81 | 10 | 35844135 | |
| Interaction | H3C1 interactions | ZNF512B CUL4B RLF RIF1 SETD2 MYBBP1A BBX PSIP1 KDM5A DDX52 SMCHD1 AHNAK DDX18 H1-2 H1-3 H1-4 ZNF638 KMT2A DIDO1 C9orf72 ADNP MECP2 DDX27 | 3.10e-13 | 901 | 79 | 23 | int:H3C1 |
| Interaction | H3-3A interactions | ZNF512B RLF RIF1 BBX PSIP1 KDM5A CWC27 SMCHD1 H1-2 H1-3 H1-4 KMT2A DIDO1 SMARCD2 ELF1 C9orf72 ADNP MECP2 DHX8 | 5.90e-11 | 749 | 79 | 19 | int:H3-3A |
| Interaction | SIRT7 interactions | CUL4B RIF1 MYBBP1A ATR DDX52 SMCHD1 AHNAK DDX18 RPF2 H1-3 H1-4 ZNF638 EIF5B KMT2A DIDO1 ADNP DDX27 DHX8 | 4.41e-10 | 744 | 79 | 18 | int:SIRT7 |
| Interaction | H2BC21 interactions | CUL4B RLF RIF1 PSIP1 DDX52 SMCHD1 AHNAK H1-2 H1-3 H1-4 ZNF638 KMT2A DIDO1 SMARCD2 AKAP11 ADNP MECP2 | 1.26e-09 | 696 | 79 | 17 | int:H2BC21 |
| Interaction | MYCN interactions | ZNF512B CUL4B SETD2 MYBBP1A BBX PSIP1 DDX52 SMCHD1 DDX18 WBP4 RPF2 H1-2 H1-4 ZNF638 EIF5B KMT2A DIDO1 SMARCD2 RNF13 POLR2M ADNP MECP2 DDX27 | 1.47e-09 | 1373 | 79 | 23 | int:MYCN |
| Interaction | H2BC12 interactions | ADAMTS12 SMCHD1 AHNAK H1-2 H1-3 H1-4 ZNF638 EIF5B KMT2A DIDO1 C9orf72 DDX27 | 4.44e-09 | 322 | 79 | 12 | int:H2BC12 |
| Interaction | H2BC8 interactions | ZNF512B RLF RIF1 BBX PSIP1 CWC27 SMCHD1 H1-4 KMT2A DIDO1 ELF1 AKAP11 ADNP MECP2 DHX8 | 5.77e-09 | 576 | 79 | 15 | int:H2BC8 |
| Interaction | UHRF2 interactions | 5.88e-09 | 200 | 79 | 10 | int:UHRF2 | |
| Interaction | SMC5 interactions | ZNF512B CUL4B RIF1 SETD2 MYBBP1A BBX PSIP1 SMCHD1 AHNAK DDX18 WBP4 H1-2 ZNF638 EIF5B KMT2A DIDO1 ADNP MECP2 FKBP3 | 7.26e-09 | 1000 | 79 | 19 | int:SMC5 |
| Interaction | NR2C2 interactions | CUL4B S100A4 NRIP1 HBS1L MYBBP1A SH3RF1 KDM5A DDX52 SMCHD1 AHNAK DDX18 RPF2 H1-2 H1-3 H1-4 EIF5B KMT2A DIDO1 SMARCD2 ADNP DDX27 YARS1 | 1.23e-08 | 1403 | 79 | 22 | int:NR2C2 |
| Interaction | CBX3 interactions | ZNF512B CUL4B RLF RIF1 SETD2 BBX PSIP1 CWC27 SMCHD1 H1-4 EIF5B KMT2A ADNP MECP2 DHX8 | 2.66e-08 | 646 | 79 | 15 | int:CBX3 |
| Interaction | XRCC6 interactions | ZNF512B CUL4B RIF1 MYBBP1A BBX PSIP1 CWC27 SMCHD1 PAEP WBP4 ZNF638 KMT2A DIDO1 C9orf72 ADNP MECP2 DHX8 | 8.79e-08 | 928 | 79 | 17 | int:XRCC6 |
| Interaction | CIT interactions | NRIP1 RIF1 HBS1L C5orf34 MYBBP1A PSIP1 SMCHD1 AHNAK DDX18 RPF2 H1-2 H1-3 H1-4 ZNF638 EIF5B KMT2A DIDO1 SMARCD2 ELF1 ADNP DHX8 | 1.12e-07 | 1450 | 79 | 21 | int:CIT |
| Interaction | NUP43 interactions | RLF RIF1 SETD2 BBX PSIP1 KDM5A DDX18 H1-2 H1-4 KMT2A ELF1 MECP2 DDX27 DHX8 | 1.28e-07 | 625 | 79 | 14 | int:NUP43 |
| Interaction | NPM1 interactions | CUL4B KANSL1L SETD2 MYBBP1A PSIP1 ATR DDX52 DDX18 RPF2 H1-2 H1-3 H1-4 ZNF638 KMT2A DIDO1 AKAP11 C9orf72 MECP2 DDX27 | 1.34e-07 | 1201 | 79 | 19 | int:NPM1 |
| Interaction | ZNF330 interactions | ZNF512B RLF MYBBP1A BBX PSIP1 CWC27 DDX52 SMCHD1 DDX18 KMT2A MECP2 DDX27 | 1.60e-07 | 446 | 79 | 12 | int:ZNF330 |
| Interaction | H3-4 interactions | SETD2 TADA1 DNAH10 KDM5A AHNAK H1-2 H1-3 H1-4 KMT2A DIDO1 C9orf72 ADNP | 1.67e-07 | 448 | 79 | 12 | int:H3-4 |
| Interaction | PRC1 interactions | NRIP1 C5orf34 MYBBP1A PSIP1 DDX52 AHNAK DDX18 RPF2 H1-2 H1-3 H1-4 ZNF638 EIF5B MECP2 DDX27 FAM83B DHX8 | 1.73e-07 | 973 | 79 | 17 | int:PRC1 |
| Interaction | H1-4 interactions | ZNF512B MYBBP1A BBX DDX18 RPF2 H1-2 H1-3 H1-4 ZNF638 EIF5B KMT2A C9orf72 DDX27 DHX8 | 2.30e-07 | 656 | 79 | 14 | int:H1-4 |
| Interaction | H1-6 interactions | 2.79e-07 | 229 | 79 | 9 | int:H1-6 | |
| Interaction | DDX23 interactions | ZNF512B SETD2 MYBBP1A CWC27 DDX52 DDX18 WBP4 ZNF638 C9orf72 MECP2 DDX27 DHX8 | 3.50e-07 | 480 | 79 | 12 | int:DDX23 |
| Interaction | RPL31 interactions | ZNF512B CUL4B MYBBP1A BBX DDX52 DDX18 RPF2 H1-2 H1-3 H1-4 C9orf72 ADNP DDX27 DHX8 | 3.55e-07 | 680 | 79 | 14 | int:RPL31 |
| Interaction | BRD3 interactions | RIF1 BBX PSIP1 SMCHD1 DDX18 H1-3 EIF5B KMT2A SMARCD2 RAB11FIP1 ADNP MECP2 | 4.75e-07 | 494 | 79 | 12 | int:BRD3 |
| Interaction | H3C3 interactions | ZNF512B RLF RIF1 BBX KDM5A CWC27 SMCHD1 KMT2A DIDO1 ADNP MECP2 DHX8 | 4.86e-07 | 495 | 79 | 12 | int:H3C3 |
| Interaction | EFTUD2 interactions | RIF1 HBS1L MYBBP1A PSIP1 CWC27 SMCHD1 AHNAK DDX18 WBP4 H1-2 CARS1 ZNF638 EIF5B NAV1 DIDO1 PSME1 C9orf72 MECP2 FKBP3 YARS1 | 5.24e-07 | 1449 | 79 | 20 | int:EFTUD2 |
| Interaction | H2AC11 interactions | 5.44e-07 | 248 | 79 | 9 | int:H2AC11 | |
| Interaction | SRSF6 interactions | SETD2 MYBBP1A BBX DDX18 RPF2 H1-2 ZNF638 KMT2A C9orf72 MECP2 DDX27 DHX8 | 5.76e-07 | 503 | 79 | 12 | int:SRSF6 |
| Interaction | CHD4 interactions | ZNF512B MYBBP1A PSIP1 ATR DDX52 AHNAK DDX18 H1-2 H1-4 ZNF638 KMT2A SMARCD2 ADNP MECP2 DDX27 DHX8 | 5.83e-07 | 938 | 79 | 16 | int:CHD4 |
| Interaction | H2AC4 interactions | CUL4B MYBBP1A DNAH10 DDX52 DDX18 H1-2 H1-3 H1-4 ZNF638 KMT2A C9orf72 DDX27 | 6.13e-07 | 506 | 79 | 12 | int:H2AC4 |
| Interaction | NOP2 interactions | MYBBP1A BBX DDX52 DDX18 RPF2 H1-2 H1-4 C9orf72 MECP2 DDX27 DHX8 | 6.52e-07 | 416 | 79 | 11 | int:NOP2 |
| Interaction | MNDA interactions | 7.32e-07 | 188 | 79 | 8 | int:MNDA | |
| Interaction | RRS1 interactions | 9.59e-07 | 345 | 79 | 10 | int:RRS1 | |
| Interaction | HDAC1 interactions | ZNF512B CUL4B RLF NRIP1 MYBBP1A BBX ATR KDM5A AHNAK ZNF638 NAV1 KMT2A SMARCD2 C9orf72 ADNP MECP2 FKBP3 | 1.06e-06 | 1108 | 79 | 17 | int:HDAC1 |
| Interaction | SNRNP40 interactions | CUL4B SETD2 DDX52 DDX18 WBP4 H1-2 H1-4 KMT2A ELF1 C9orf72 MECP2 DDX27 DHX8 | 1.08e-06 | 637 | 79 | 13 | int:SNRNP40 |
| Interaction | POLR1E interactions | ZNF512B RLF MYBBP1A BBX DDX52 DDX18 EIF5B KMT2A POLR2M C9orf72 | 1.09e-06 | 350 | 79 | 10 | int:POLR1E |
| Interaction | H3C15 interactions | 1.51e-06 | 207 | 79 | 8 | int:H3C15 | |
| Interaction | COIL interactions | ZNF512B ADAMTS12 RLF BBX LACTB2 DDX52 DDX18 WBP4 C9orf72 MECP2 YARS1 DHX8 | 1.53e-06 | 552 | 79 | 12 | int:COIL |
| Interaction | TERF2IP interactions | ZNF512B RIF1 SETD2 BBX PSIP1 CWC27 SMCHD1 ZNF638 KMT2A DIDO1 ADNP DHX8 | 1.53e-06 | 552 | 79 | 12 | int:TERF2IP |
| Interaction | PPIA interactions | CUL4B RIF1 BBX PSIP1 AHNAK WBP4 RPF2 SH2D3C CARS1 DIDO1 SMARCD2 C9orf72 MECP2 FKBP3 DHX8 | 1.57e-06 | 888 | 79 | 15 | int:PPIA |
| Interaction | MEN1 interactions | ZNF512B CUL4B RIF1 MYBBP1A PSIP1 DDX52 SMCHD1 DDX18 RPF2 ZNF638 EIF5B KMT2A DIDO1 ADNP DDX27 DHX8 | 1.97e-06 | 1029 | 79 | 16 | int:MEN1 |
| Interaction | CENPA interactions | 2.13e-06 | 377 | 79 | 10 | int:CENPA | |
| Interaction | KRR1 interactions | 2.23e-06 | 379 | 79 | 10 | int:KRR1 | |
| Interaction | NUCKS1 interactions | 2.38e-06 | 220 | 79 | 8 | int:NUCKS1 | |
| Interaction | HMGN2 interactions | 2.55e-06 | 222 | 79 | 8 | int:HMGN2 | |
| Interaction | GNL2 interactions | 2.63e-06 | 386 | 79 | 10 | int:GNL2 | |
| Interaction | SFN interactions | RALGAPA1 STOX2 SH3RF1 H1-2 H1-3 ZNF638 EIF5B NAV1 KMT2A AKAP11 RAB11FIP1 C9orf72 FAM83B | 2.70e-06 | 692 | 79 | 13 | int:SFN |
| Interaction | ZNF668 interactions | 2.91e-06 | 226 | 79 | 8 | int:ZNF668 | |
| Interaction | DKC1 interactions | 3.09e-06 | 393 | 79 | 10 | int:DKC1 | |
| Interaction | POLR1G interactions | ZNF512B MYBBP1A BBX CWC27 DDX52 SMCHD1 DDX18 KMT2A POLR2M MECP2 DDX27 | 3.13e-06 | 489 | 79 | 11 | int:POLR1G |
| Interaction | SRPK2 interactions | S100A4 HBS1L SETD2 MYBBP1A DDX52 SMCHD1 DDX18 RPF2 H1-4 ZNF638 DIDO1 DDX27 DHX8 | 3.98e-06 | 717 | 79 | 13 | int:SRPK2 |
| Interaction | GLYR1 interactions | 4.40e-06 | 239 | 79 | 8 | int:GLYR1 | |
| Interaction | H1-1 interactions | MYBBP1A DDX52 DDX18 RPF2 H1-2 H1-3 H1-4 C9orf72 ADNP DDX27 DHX8 | 4.42e-06 | 507 | 79 | 11 | int:H1-1 |
| Interaction | NAA40 interactions | ZNF512B RIF1 SETD2 MYBBP1A PSIP1 SMCHD1 AHNAK H1-4 ZNF638 EIF5B KMT2A DIDO1 ADNP MECP2 FKBP3 | 5.11e-06 | 978 | 79 | 15 | int:NAA40 |
| Interaction | HMGA1 interactions | 5.44e-06 | 419 | 79 | 10 | int:HMGA1 | |
| Interaction | PPP1CC interactions | RIF1 MYBBP1A KDM5A DDX52 H1-2 ZNF638 NAV1 AKAP11 PSME1 RAB11FIP1 C9orf72 MECP2 FAM83B | 5.44e-06 | 738 | 79 | 13 | int:PPP1CC |
| Interaction | FTSJ3 interactions | 5.79e-06 | 422 | 79 | 10 | int:FTSJ3 | |
| Interaction | H2BC5 interactions | 5.85e-06 | 331 | 79 | 9 | int:H2BC5 | |
| Interaction | SNW1 interactions | CUL4B TSNAXIP1 RIF1 ATR CWC27 SMCHD1 AHNAK WBP4 ZNF638 KMT2A C9orf72 MECP2 DHX8 | 6.20e-06 | 747 | 79 | 13 | int:SNW1 |
| Interaction | BRD2 interactions | 6.69e-06 | 429 | 79 | 10 | int:BRD2 | |
| Interaction | APEX1 interactions | ZNF512B RLF RALGAPA1 RIF1 HBS1L SETD2 BBX PSIP1 SMCHD1 AHNAK H1-2 ZNF638 KMT2A DIDO1 PSME1 MECP2 DDX27 | 6.80e-06 | 1271 | 79 | 17 | int:APEX1 |
| Interaction | H2BC18 interactions | 6.80e-06 | 180 | 79 | 7 | int:H2BC18 | |
| Interaction | PUM3 interactions | 6.88e-06 | 254 | 79 | 8 | int:PUM3 | |
| Interaction | NSD1 interactions | 7.30e-06 | 119 | 79 | 6 | int:NSD1 | |
| Interaction | FGFBP1 interactions | 7.49e-06 | 257 | 79 | 8 | int:FGFBP1 | |
| Interaction | H2BC4 interactions | 7.93e-06 | 259 | 79 | 8 | int:H2BC4 | |
| Interaction | RRP8 interactions | 7.93e-06 | 259 | 79 | 8 | int:RRP8 | |
| Interaction | REXO4 interactions | 8.39e-06 | 261 | 79 | 8 | int:REXO4 | |
| Interaction | RPLP0 interactions | CUL4B MYBBP1A BBX DDX18 RPF2 H1-2 H1-4 EIF5B KMT2A C9orf72 MECP2 DDX27 | 9.48e-06 | 660 | 79 | 12 | int:RPLP0 |
| Interaction | UTP23 interactions | 1.00e-05 | 191 | 79 | 7 | int:UTP23 | |
| Interaction | RPL14 interactions | CUL4B MYBBP1A DDX52 AHNAK DDX18 RPF2 H1-4 C9orf72 MECP2 DDX27 DHX8 | 1.02e-05 | 554 | 79 | 11 | int:RPL14 |
| Interaction | YY1 interactions | ZNF512B RIF1 SMCHD1 ZNF638 KMT2A DIDO1 ELF1 ADNP MECP2 FKBP3 | 1.10e-05 | 454 | 79 | 10 | int:YY1 |
| Interaction | CDC42 interactions | RALGAPA1 MYBBP1A DENND6A MOSPD2 BBX PSIP1 ATR DDX52 AHNAK DDX18 ARL13B EIF5B RAB11FIP1 MECP2 FKBP3 YARS1 FAM83B | 1.15e-05 | 1323 | 79 | 17 | int:CDC42 |
| Interaction | KIF20A interactions | RALGAPA1 NRIP1 MYBBP1A PSIP1 AHNAK DDX18 H1-2 H1-3 H1-4 ZNF638 DIDO1 GNAO1 DDX27 YARS1 FAM83B | 1.23e-05 | 1052 | 79 | 15 | int:KIF20A |
| Interaction | NCL interactions | CUL4B SETD2 MYBBP1A DDX18 RPF2 H1-2 H1-3 H1-4 EIF5B KMT2A DIDO1 C9orf72 MECP2 | 1.26e-05 | 798 | 79 | 13 | int:NCL |
| Interaction | RPF1 interactions | 1.32e-05 | 132 | 79 | 6 | int:RPF1 | |
| Interaction | RBM28 interactions | 1.37e-05 | 368 | 79 | 9 | int:RBM28 | |
| Interaction | DOT1L interactions | ZNF512B RIF1 MYBBP1A PSIP1 DDX52 DDX18 RPF2 H1-2 H1-4 ZNF638 KMT2A DDX27 DHX8 | 1.42e-05 | 807 | 79 | 13 | int:DOT1L |
| Interaction | AATF interactions | 1.62e-05 | 376 | 79 | 9 | int:AATF | |
| Interaction | RBBP5 interactions | 1.67e-05 | 287 | 79 | 8 | int:RBBP5 | |
| Interaction | IFI16 interactions | MYBBP1A DDX52 SMCHD1 DDX18 PAEP RPF2 H1-2 H1-3 H1-4 ZNF638 DDX27 DHX8 | 2.07e-05 | 714 | 79 | 12 | int:IFI16 |
| Interaction | USP36 interactions | RIF1 MYBBP1A DDX52 DDX18 RPF2 H1-2 H1-4 ZNF638 EIF5B DDX27 DHX8 | 2.11e-05 | 599 | 79 | 11 | int:USP36 |
| Interaction | HECTD1 interactions | NRIP1 RIF1 HBS1L MYBBP1A PSIP1 DDX52 SMCHD1 DDX18 H1-4 DIDO1 C9orf72 DDX27 FKBP3 DHX8 | 2.55e-05 | 984 | 79 | 14 | int:HECTD1 |
| Interaction | SNRNP70 interactions | CUL4B MYBBP1A BBX PSIP1 DDX52 DDX18 WBP4 RPF2 H1-2 ZNF638 EIF5B C9orf72 MECP2 DHX8 | 2.55e-05 | 984 | 79 | 14 | int:SNRNP70 |
| Interaction | PRKRA interactions | 2.64e-05 | 400 | 79 | 9 | int:PRKRA | |
| Interaction | RPL36 interactions | 2.69e-05 | 504 | 79 | 10 | int:RPL36 | |
| Interaction | NOP58 interactions | 2.83e-05 | 309 | 79 | 8 | int:NOP58 | |
| Interaction | HDAC2 interactions | ZNF512B CUL4B NRIP1 MYBBP1A ATR KDM5A AHNAK H1-3 KMT2A SMARCD2 C9orf72 MECP2 FKBP3 | 2.93e-05 | 865 | 79 | 13 | int:HDAC2 |
| Interaction | RNF2 interactions | MYBBP1A DDX52 SMCHD1 DDX18 RPF2 H1-2 H1-3 H1-4 ZNF638 KMT2A SMARCD2 ADNP DDX27 | 2.97e-05 | 866 | 79 | 13 | int:RNF2 |
| Interaction | RPL18 interactions | CUL4B MYBBP1A DDX52 DDX18 RPF2 H1-2 H1-4 C9orf72 MECP2 DDX27 | 3.07e-05 | 512 | 79 | 10 | int:RPL18 |
| Interaction | IRAK4 interactions | 3.15e-05 | 46 | 79 | 4 | int:IRAK4 | |
| Interaction | MIDN interactions | MYBBP1A PSIP1 DDX52 DDX18 ARL13B H1-2 H1-3 H1-4 RAB11FIP1 C9orf72 DDX27 | 3.16e-05 | 626 | 79 | 11 | int:MIDN |
| Interaction | RPS6 interactions | ZNF512B CUL4B MYBBP1A BBX PSIP1 DDX52 DDX18 RPF2 H1-4 EIF5B C9orf72 MECP2 DDX27 | 3.26e-05 | 874 | 79 | 13 | int:RPS6 |
| Interaction | MECP2 interactions | ZNF512B SETD2 MYBBP1A BBX PSIP1 KDM5A DDX18 RPF2 ZNF638 EIF5B DIDO1 SMARCD2 ADNP MECP2 FKBP3 DHX8 | 3.27e-05 | 1287 | 79 | 16 | int:MECP2 |
| Interaction | CEBPB interactions | HBS1L PSIP1 SMCHD1 AHNAK DDX18 H1-2 H1-3 H1-4 ZNF638 EIF5B SMARCD2 PSME1 ADNP DDX27 FKBP3 YARS1 DHX8 | 3.52e-05 | 1443 | 79 | 17 | int:CEBPB |
| Interaction | RRP15 interactions | 3.53e-05 | 157 | 79 | 6 | int:RRP15 | |
| Interaction | CHD3 interactions | ZNF512B RIF1 MYBBP1A PSIP1 DDX52 DDX18 H1-2 H1-4 KMT2A PSME1 ADNP DDX27 | 3.68e-05 | 757 | 79 | 12 | int:CHD3 |
| Interaction | BRD7 interactions | RIF1 HBS1L MYBBP1A DDX52 DDX18 RPF2 H1-2 EIF5B LAMA4 SMARCD2 ELF1 | 3.71e-05 | 637 | 79 | 11 | int:BRD7 |
| Interaction | HDGF interactions | 3.71e-05 | 321 | 79 | 8 | int:HDGF | |
| Interaction | TBX1 interactions | 3.79e-05 | 17 | 79 | 3 | int:TBX1 | |
| Interaction | RPF2 interactions | 3.91e-05 | 236 | 79 | 7 | int:RPF2 | |
| GeneFamily | DEAD-box helicases | 2.38e-04 | 42 | 52 | 3 | 499 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 1.34e-03 | 19 | 52 | 2 | 131 | |
| GeneFamily | PHD finger proteins | 2.21e-03 | 90 | 52 | 3 | 88 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 2.33e-03 | 25 | 52 | 2 | 504 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.29e-03 | 34 | 52 | 2 | 487 | |
| GeneFamily | Histones | 4.52e-03 | 116 | 52 | 3 | 864 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CUL4B RLF NRIP1 RIF1 STOX2 MOSPD2 BBX ATR LACTB2 CWC27 SMCHD1 WBP4 ZNF638 EIF5B RNF13 AKAP11 ZCCHC2 | 1.40e-11 | 656 | 81 | 17 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RLF DOK5 NRIP1 RIF1 SETD2 BBX ATR KDM5A SMCHD1 WBP4 ZNF638 CHSY1 RNF13 AKAP11 ADNP MECP2 | 6.73e-09 | 856 | 81 | 16 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.05e-08 | 300 | 81 | 10 | M8702 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | S100A4 RALGAPA1 SEMA4D RIF1 SETD2 BBX PSIP1 ATR KDM5A SMCHD1 AHNAK SH2D3C ZNF638 CHSY1 KMT2A ELF1 AKAP11 PSME1 MECP2 | 1.02e-07 | 1492 | 81 | 19 | M40023 |
| Coexpression | GSE6259_DEC205_POS_DC_VS_BCELL_DN | 1.07e-06 | 172 | 81 | 7 | M6772 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.74e-06 | 466 | 81 | 10 | M13522 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | CUL4B RLF RIF1 C5orf34 ATR DDX52 AHNAK RPF2 CARS1 EIF5B DDX27 YARS1 | 2.14e-06 | 721 | 81 | 12 | M10237 |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP | 2.92e-06 | 200 | 81 | 7 | M5119 | |
| Coexpression | EHLERS_ANEUPLOIDY_UP | 7.11e-06 | 40 | 81 | 4 | M7775 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | RLF SEMA4D NRIP1 BBX EGR3 CHSY1 DIDO1 ELF1 POLR2M ZCCHC2 RAB11FIP1 DDX27 | 1.06e-05 | 844 | 81 | 12 | M41129 |
| Coexpression | WANG_LMO4_TARGETS_DN | 1.61e-05 | 361 | 81 | 8 | M12674 | |
| Coexpression | ERBB2_UP.V1_DN | 3.39e-05 | 197 | 81 | 6 | M2635 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 3.49e-05 | 198 | 81 | 6 | MM17083 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 3.59e-05 | 199 | 81 | 6 | M7319 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP | 3.59e-05 | 199 | 81 | 6 | M8863 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP | 3.69e-05 | 200 | 81 | 6 | M5610 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | RIF1 PSIP1 DDX52 SMCHD1 DDX18 H1-4 EIF5B DIDO1 SMARCD2 ELF1 GNAO1 PSME1 ADNP DDX27 | 8.69e-05 | 1394 | 81 | 14 | M9585 |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 1.45e-04 | 33 | 81 | 3 | M9167 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.12e-10 | 200 | 81 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.87e-09 | 197 | 81 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.23e-09 | 200 | 81 | 8 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.94e-07 | 178 | 81 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 184 | 81 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.23e-06 | 188 | 81 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-06 | 196 | 81 | 6 | e4c76e7ad68455e51fe93ce588bcec9383f8654b | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.76e-06 | 200 | 81 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | BAL-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 1.79e-05 | 177 | 81 | 5 | 939487a05311b66edfc3f44a7955fbf25266d6bf | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-05 | 185 | 81 | 5 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 185 | 81 | 5 | 60e223cd0ed3022e3f98ce6b766bedd14c534885 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.39e-05 | 188 | 81 | 5 | 2156f1bc849ff1cb09ae296d13bedd913ae6b43b | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 189 | 81 | 5 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 194 | 81 | 5 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 194 | 81 | 5 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 194 | 81 | 5 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 195 | 81 | 5 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 2.92e-05 | 196 | 81 | 5 | 7c3a99f0893c43d8c7980b560503844573d3b03c | |
| ToppCell | BL-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.99e-05 | 197 | 81 | 5 | fb70918867fbd111bb192a797dcafed5f39ea299 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.99e-05 | 197 | 81 | 5 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-05 | 197 | 81 | 5 | 3cd1c816bc7a57278b2ef615b69545356ab8f522 | |
| ToppCell | BL-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.07e-05 | 198 | 81 | 5 | 1c0227e58a64c0bf509bfb9578fb91277316b120 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.07e-05 | 198 | 81 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 3.14e-05 | 199 | 81 | 5 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.14e-05 | 199 | 81 | 5 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.22e-05 | 200 | 81 | 5 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.06e-05 | 121 | 81 | 4 | a5962d1c476e6966870832b72d511607e047248b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 52 | 81 | 3 | d654e2b77c53ed5319015598b68a20bf4416380c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.93e-04 | 157 | 81 | 4 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.93e-04 | 157 | 81 | 4 | f896997490bb2eec598c6581f161220e70f9a991 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.93e-04 | 157 | 81 | 4 | 14a8516346a89a89f1119b744625bd9844a74a03 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-04 | 159 | 81 | 4 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | Control-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 2.07e-04 | 160 | 81 | 4 | 174775fb5cc7b478c6cd04f7c565738648ec2fc3 | |
| ToppCell | PBMC-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 2.07e-04 | 160 | 81 | 4 | 4dac64e58d9366c399f3d830848ccb720d400be7 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.12e-04 | 161 | 81 | 4 | 7e0b8119cea208c0b4a0dffdf94ff6137d0b4c90 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Npy_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.16e-04 | 64 | 81 | 3 | 28acc0d394b8cd2fd93ae5e0801f0ff1dd4b16ac | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Npy_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.16e-04 | 64 | 81 | 3 | 61414e0fa2242f156f0f45f8733b831b7f965dd8 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-04 | 162 | 81 | 4 | 2fd6e8f48b48d509a7533cec2f79089513c34a2f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.28e-04 | 164 | 81 | 4 | a5227971a71345854e0538e42da684de87febda0 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 168 | 81 | 4 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 168 | 81 | 4 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.55e-04 | 169 | 81 | 4 | 4a5d023ffcf83312d29b1d215eb6b744ef1a0777 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_C|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-04 | 68 | 81 | 3 | 1f432e77d83bf6900c29c5c07fefc8662440490b | |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.61e-04 | 170 | 81 | 4 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 173 | 81 | 4 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-04 | 174 | 81 | 4 | 2627c3983009839fedbc5e3f628739dc026447f4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 174 | 81 | 4 | 723848d2f8ae9cf4f15d4b4a130f9a64dab443c7 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-04 | 174 | 81 | 4 | 507a33e58f62e2b72f0bcc743e84dbd0bf705a15 | |
| ToppCell | facs-Liver-Non-hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-04 | 177 | 81 | 4 | f73ed860685a724591d0f543a9ac4e868aff92f5 | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 3.11e-04 | 178 | 81 | 4 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 3.31e-04 | 181 | 81 | 4 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 3.31e-04 | 181 | 81 | 4 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-04 | 182 | 81 | 4 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-04 | 182 | 81 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-04 | 182 | 81 | 4 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-04 | 182 | 81 | 4 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 183 | 81 | 4 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.45e-04 | 183 | 81 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.45e-04 | 183 | 81 | 4 | a492b3827d2c368d33a7a5118748beaf4d7f6797 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.52e-04 | 184 | 81 | 4 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.52e-04 | 184 | 81 | 4 | 1c56378b3888c46258d446b47de4d6282fe74b0d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 184 | 81 | 4 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.52e-04 | 184 | 81 | 4 | a45980306c4e697a2703bed72a7b48fb23d942f4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 184 | 81 | 4 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 184 | 81 | 4 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 185 | 81 | 4 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 185 | 81 | 4 | dc59b8dc459a3c444c9634a0d438cbef54c40036 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 185 | 81 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.60e-04 | 185 | 81 | 4 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 185 | 81 | 4 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 3.67e-04 | 186 | 81 | 4 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 186 | 81 | 4 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 186 | 81 | 4 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 186 | 81 | 4 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 186 | 81 | 4 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-04 | 187 | 81 | 4 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.82e-04 | 188 | 81 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 3.82e-04 | 188 | 81 | 4 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 3.82e-04 | 188 | 81 | 4 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 188 | 81 | 4 | 59b71462338a7efbacf46577cb07e9db3363afee | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-04 | 189 | 81 | 4 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-04 | 189 | 81 | 4 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.98e-04 | 190 | 81 | 4 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-04 | 190 | 81 | 4 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | IPF-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 3.98e-04 | 190 | 81 | 4 | ffa890138394f579fee53fcfac6c121bf86adc26 | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 3.98e-04 | 190 | 81 | 4 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.06e-04 | 191 | 81 | 4 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 3'_v3-bone_marrow|World / Manually curated celltypes from each tissue | 4.06e-04 | 191 | 81 | 4 | 7b759831f1b1c8575c31f67d0d9eb11c6a833cf3 | |
| ToppCell | 5'|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-04 | 191 | 81 | 4 | 0e752756e9d1b444930522efc0fdca072d42535f | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.06e-04 | 191 | 81 | 4 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-04 | 191 | 81 | 4 | 63d4226a8b59f648bdc9f41e4b2d750dfa342034 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 4.14e-04 | 192 | 81 | 4 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 4.14e-04 | 192 | 81 | 4 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.14e-04 | 192 | 81 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.22e-04 | 193 | 81 | 4 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 81 | 4 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 4.22e-04 | 193 | 81 | 4 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.30e-04 | 194 | 81 | 4 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Oligodendrocyte.Tnf.Igsf8-Ctps_(Ctps)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.33e-04 | 81 | 81 | 3 | 4529c9b40330361d999a8532268e0ee935affd8d | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 4.39e-04 | 195 | 81 | 4 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.02e-09 | 50 | 51 | 7 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.32e-07 | 191 | 79 | 8 | 4279_DN | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.44e-06 | 183 | 79 | 7 | 3232_DN | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 4.11e-06 | 188 | 79 | 7 | 3291_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.56e-06 | 191 | 79 | 7 | 6020_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.31e-05 | 175 | 79 | 6 | 1058_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.52e-05 | 177 | 79 | 6 | 985_DN | |
| Drug | Ellipticine [519-23-3]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.87e-05 | 180 | 79 | 6 | 5779_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.87e-05 | 180 | 79 | 6 | 4541_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.12e-05 | 182 | 79 | 6 | 3887_DN | |
| Drug | Ellipticine [519-23-3]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 4.12e-05 | 182 | 79 | 6 | 6253_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 4.24e-05 | 183 | 79 | 6 | 6925_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 5.08e-05 | 189 | 79 | 6 | 4304_DN | |
| Drug | Homocysteine | 6.04e-05 | 195 | 79 | 6 | ctd:D006710 | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 6.04e-05 | 195 | 79 | 6 | 3237_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 6.04e-05 | 195 | 79 | 6 | 6159_DN | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 3573_DN | |
| Drug | Monocrotaline [315-22-0]; Down 200; 12.2uM; HL60; HG-U133A | 6.40e-05 | 197 | 79 | 6 | 1757_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 2249_UP | |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; HL60; HG-U133A | 6.58e-05 | 198 | 79 | 6 | 1594_UP | |
| Drug | AC1L45LU | 7.97e-05 | 205 | 79 | 6 | CID000151069 | |
| Disease | Neurodevelopmental Disorders | 5.92e-06 | 93 | 81 | 5 | C1535926 | |
| Disease | autoimmune disease (implicated_via_orthology) | 4.45e-05 | 4 | 81 | 2 | DOID:417 (implicated_via_orthology) | |
| Disease | neutrophil percentage of leukocytes | 2.72e-04 | 610 | 81 | 8 | EFO_0007990 | |
| Disease | Schizophrenia | 7.03e-04 | 883 | 81 | 9 | C0036341 | |
| Disease | prostate carcinoma | 7.49e-04 | 891 | 81 | 9 | EFO_0001663 | |
| Disease | Muscle hypotonia | 9.85e-04 | 17 | 81 | 2 | C0026827 | |
| Disease | myeloid white cell count | 1.07e-03 | 937 | 81 | 9 | EFO_0007988 | |
| Disease | Myeloid Leukemia | 1.11e-03 | 18 | 81 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.11e-03 | 18 | 81 | 2 | C0023466 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.17e-03 | 75 | 81 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 1.34e-03 | 173 | 81 | 4 | C0023467 | |
| Disease | Intellectual Disability | 1.46e-03 | 447 | 81 | 6 | C3714756 | |
| Disease | basophil count | 2.15e-03 | 483 | 81 | 6 | EFO_0005090 | |
| Disease | lymphocyte count | NRIP1 HBS1L SETD2 C5orf34 SLC12A1 DNAH10 AHNAK DDX18 ZNF638 ELF1 GNAO1 | 2.15e-03 | 1464 | 81 | 11 | EFO_0004587 |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.50e-03 | 27 | 81 | 2 | DOID:10584 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLNPKLVGKLKDKAF | 126 | Q495M9 | |
| GKLKFLFGQKKKAPS | 246 | A9YTQ3 | |
| STFKDKNKNDGLKPK | 141 | Q9H2P0 | |
| KKFGPKSSKKFDILV | 276 | Q9Y2R4 | |
| KKTVSGFQKLEKLDP | 151 | Q9Y6F7 | |
| TPNISVKKKNKDGKG | 191 | P32519 | |
| KKFKKTKPKEDCLLG | 671 | Q8WY36 | |
| VKKLKPKGTKNFSLL | 191 | Q6UX04 | |
| GFFVKKKEKKIPSAE | 36 | H3BNL8 | |
| KLNKKAASGEAKPKV | 106 | P16403 | |
| LDKKPSKLKSKSSGN | 76 | Q96NL8 | |
| LNIEGKSKKSRFKLP | 3341 | Q09666 | |
| TKKLKGELAKEFAPA | 1121 | Q9UKA4 | |
| RPSLESANGKKKTKK | 336 | Q3SXY8 | |
| PAKKQKQGKKSVFDE | 736 | Q96GQ7 | |
| CLDDIPKKKGLKSKV | 451 | P58397 | |
| NKSTGEVTKKKPKFL | 621 | Q9Y450 | |
| EKKVLGEKTENPKKF | 86 | P09466 | |
| YKQKKLGEPSCNKLK | 96 | A0AUZ9 | |
| FLKPGKVKVELKESK | 401 | P18428 | |
| KFGELLKPQKKGKTS | 526 | A6NIV6 | |
| ASKKEVKGSPSFLKK | 756 | Q5T0W9 | |
| KKLEKEGKIFSNTDP | 266 | Q53H82 | |
| KSAIFKGELKPEAAK | 546 | Q86UK5 | |
| LLGNPNKGKSEKKEK | 716 | P48552 | |
| FKKASSKGPKRLEKF | 31 | Q9P104 | |
| AEPDTKKAKTENKGK | 121 | Q9NVP1 | |
| DKPRKKKLKLGADKS | 1531 | P29375 | |
| TQSPISKKRKKKGFL | 1161 | Q9BQG0 | |
| LQKPKKISLKGSDGK | 2306 | Q13535 | |
| LKQKEKKAEKGGAPS | 356 | Q06889 | |
| LKKGDKTNFPKKGDV | 116 | Q00688 | |
| EKAANPSGKKKLKIF | 371 | Q9BTC0 | |
| VKKLKNLKTLDSKPG | 386 | Q8IWF6 | |
| LCKGLQEKFFKRKPK | 31 | Q96PG1 | |
| KSGQKKLLKKAALFS | 91 | Q5JRC9 | |
| KLNKKAASGEAKPKA | 106 | P10412 | |
| KKLRAGKLSPLKSKF | 271 | Q03164 | |
| RNEKFICKLPDKGKK | 36 | P0CAP2 | |
| FKLNKKAASGEGKPK | 106 | P16402 | |
| NKAPKDKLVEKTGKI | 166 | Q96MH7 | |
| LKGNISLEKSKRKKP | 3751 | Q8IVF4 | |
| LKNFEKLKKPRGETK | 231 | Q06323 | |
| PGSAKKLVIKNFKDK | 191 | Q13620 | |
| IEDDTQKGKKPFKSL | 416 | Q96LT7 | |
| PKDKQALADQKKAKF | 1021 | Q14562 | |
| LLHKKGKNLSKPKAS | 1411 | Q16363 | |
| QDLQGLKDKPLKFKK | 16 | P51608 | |
| KPEGKATDKGKLAVK | 556 | Q8NEY1 | |
| SKVKAFKKPLSVFKG | 311 | Q8NHP6 | |
| SRNPFGKLKDKIKGK | 166 | Q6WKZ4 | |
| VKKKLKKAFCEPGNV | 241 | P54577 | |
| SKAIKFSVKEGKPEK | 811 | A6NHR9 | |
| LSKGQAKKLKKLFEA | 716 | P49589 | |
| PKGKKKLSSVRQKFD | 96 | Q96BN2 | |
| KKKNEPLGKLTSLFK | 791 | Q5UIP0 | |
| DDFNKLPKKAKGKAQ | 141 | O60841 | |
| KKDLFGEKIKKSPLT | 271 | P09471 | |
| DQLKKLPVHKFKKGD | 221 | O43567 | |
| GKEGDKFKLNKSELK | 21 | P26447 | |
| FKKAGKLNITKTTPK | 861 | Q13621 | |
| KTGPKKFIVKLSSKQ | 656 | P49221 | |
| KFRSALLIGKKKPKS | 766 | Q92854 | |
| LKPKKKKNISHDTFG | 246 | Q9H7B2 | |
| GKLLDDPSKQKRKFS | 236 | Q92925 | |
| TKPDKDSKKEKKGLL | 706 | Q7Z6J0 | |
| GSKSEHKEPKDKKIN | 521 | Q86X52 | |
| EKRSLSSINKKKGKP | 566 | Q9C0B9 | |
| TKDQGKKGPNKKLEK | 456 | O75475 | |
| KKGPNKKLEKEQTGS | 461 | O75475 | |
| KIKELPLKKDFCEGK | 181 | Q8NHY6 | |
| PLDKLSEQKQKKHKG | 686 | Q6GYQ0 | |
| KKIKTKDLFPSLGNE | 986 | Q13129 | |
| KKCGLIKEKKAPISF | 1516 | Q13129 | |
| PKDSEKQSKKFGLKL | 256 | Q9P2F5 | |
| TKKAAITLQKKDFPG | 241 | Q9NXL6 | |
| KPKIKFKEKNKNSDG | 246 | O75554 | |
| PFGKKFKLGKDIKSI | 376 | Q9BTF0 | |
| FKKSSAPLKSEDLGK | 351 | Q9BYW2 | |
| DSLVPKKEKKKNLAG | 826 | Q96KM6 | |
| KLKPFLKSLNEGKEG | 721 | Q8N5H7 | |
| LRFDGLVENKKPSKK | 381 | Q2TAA8 | |
| NVPFSELNLKKKKGK | 1571 | Q14966 |